Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Authors' reply.

Lin AW, Chan KC, Chan WK, Wong KH.

Hong Kong Med J. 2013 Dec;19(6):561. No abstract available.

PMID:
24310668
2.

Tuberculin sensitivity testing in human immunodeficiency virus-infected patients.

Joob B, Wiwanitkit V.

Hong Kong Med J. 2013 Dec;19(6):561. doi: 10.12809/hkmj134161. No abstract available.

PMID:
24310667
3.
4.

Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.

Wyndham-Thomas C, Dirix V, Schepers K, Martin C, Hildebrand M, Goffard JC, Domont F, Libin M, Loyens M, Locht C, Van Vooren JP, Mascart F.

BMC Infect Dis. 2015 Feb 14;15:59. doi: 10.1186/s12879-015-0796-0.

5.

Letter: Recommendations for the management of latent tuberculosis infection in IBD patients may not be applicable in all settings--author's reply.

Papay P, Winkler S, Reinisch W.

Aliment Pharmacol Ther. 2013 Feb;37(3):367-8. doi: 10.1111/apt.12173. No abstract available.

6.

Author's reply to Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients: disease activity as an influencing factor.

Mantzaris GJ, Papamichael K.

Scand J Gastroenterol. 2016 Mar;51(3):382. doi: 10.3109/00365521.2015.1093168. Epub 2015 Oct 1. No abstract available.

PMID:
26425891
7.

Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.

Bourgarit A, Baron G, Breton G, Tattevin P, Katlama C, Allavena C, Campa P, Ravaud P, Lortholary O, Carcelain G; IGRAVIH Study Group.

Ann Am Thorac Soc. 2015 Aug;12(8):1138-45. doi: 10.1513/AnnalsATS.201412-600OC. Erratum in: Ann Am Thorac Soc. 2016 Apr;13(4):576.

PMID:
26213798
8.

Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.

Elzi L, Steffen I, Furrer H, Fehr J, Cavassini M, Hirschel B, Hoffmann M, Bernasconi E, Bassetti S, Battegay M.

BMC Infect Dis. 2011 Nov 15;11:319. doi: 10.1186/1471-2334-11-319.

9.

Contact tracing in low-incidence tuberculosis settings.

van Leth F, Borgdorff M.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1566. doi: 10.5588/ijtld.11.0654. No abstract available.

PMID:
22118163
10.

Utility of QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent TB in HIV-Positive Patients in a Medium-TB Burden Country.

Khazraiyan H, Liaei ZA, Koochak HE, Ardalan FA, Ahmadinejad Z, Soltani A.

J Int Assoc Provid AIDS Care. 2016 Mar-Apr;15(2):101-6. doi: 10.1177/2325957415614645. Epub 2015 Oct 29.

PMID:
26514628
11.

Testing International Adoptees for Tuberculosis.

Priya Dhar C, Elena Gonzalez B, Dragga T, Bothe D, Mandalakas AM.

Pediatr Infect Dis J. 2015 Oct;34(10):1138-9. doi: 10.1097/INF.0000000000000829. No abstract available.

PMID:
26367807
12.

Letter: Supporting Austrian guidelines on latent tuberculosis screening.

Magalhães RK, Salgado M, Lago P, Moreira T, Magalhães M, Salgueiro P, Pedroto I.

Aliment Pharmacol Ther. 2013 Feb;37(3):366-7. doi: 10.1111/apt.12158. No abstract available.

13.

Latent tuberculosis infection and interferon-gamma release assays: what new knowledge did we gain through the Journal in 2009?

van der Werf MJ, van Leth F.

Int J Tuberc Lung Dis. 2010 Dec;14(12):1525-9. No abstract available.

PMID:
21144236
14.

Usefulness of Interferon-gamma Release Assays in the Screening of Latent Tuberculosis Infection in Immigrant and Internationally Adopted Children.

Méndez-Echevarría A, Sainz T, García-Hortelano M, Baquero-Artigao F, Mellado MJ.

Pediatr Infect Dis J. 2015 Oct;34(10):1141-2. doi: 10.1097/INF.0000000000000831. No abstract available.

PMID:
26367809
15.

Letter: Recommendations for the management of latent tuberculosis infection in IBD patients may not be applicable in all settings.

Taxonera C, Gisbert JP.

Aliment Pharmacol Ther. 2013 Feb;37(3):365-6. doi: 10.1111/apt.12154. No abstract available.

16.

Use of interferon-gamma release assay for latent tuberculosis infection screening in older adults exposed to tuberculosis in a nursing home.

Katsenos S, Nikolopoulou M, Gartzonika C, Manda-Stachouli C, Gogali A, Grypaiou C, Mavridis A, Constantopoulos SH, Daskalopoulos G.

J Am Geriatr Soc. 2011 May;59(5):858-62. doi: 10.1111/j.1532-5415.2011.03367.x. Epub 2011 Apr 21.

PMID:
21517785
17.

Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study.

Joshi R, Narang U, Zwerling A, Jain D, Jain V, Kalantri S, Pai M.

Eur Respir J. 2011 Dec;38(6):1475-7. doi: 10.1183/09031936.00014611. No abstract available.

18.

The positive predictive value of T-spot.TB and tuberculin skin test in patients with silicosis.

Hernández-Garduño E.

Am J Respir Crit Care Med. 2011 Jan 15;183(2):277; author reply 277-8. No abstract available.

PMID:
21242595
19.

Tuberculin skin test reactivity is dependent on host genetic background in Colombian tuberculosis household contacts.

Cobat A, Barrera LF, Henao H, Arbeláez P, Abel L, García LF, Schurr E, Alcaïs A.

Clin Infect Dis. 2012 Apr;54(7):968-71. doi: 10.1093/cid/cir972. Epub 2012 Jan 30.

20.

Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients: Disease activity as an influencing factor.

Onal IK, Alizadeh N, Sargin ZG.

Scand J Gastroenterol. 2016 Mar;51(3):381. doi: 10.3109/00365521.2015.1092578. Epub 2015 Oct 6. No abstract available.

PMID:
26439899

Supplemental Content

Support Center